Blog

European Health Data Space

LynxCare X Dedalus

We are thrilled to announce our partnership with Dedalus, transforming Real-World Data access in Europe. By combining LynxCare’s disease-specific Natural Language Processing capabilities and Dedalus’ healthcare expertise, we're set to facilitate the access and curating of fresh clinical data directly from the hospital information system. This collaboration empowers healthcare institutions and life sciences companies with accurate patient insights for more informed clinical decisions and research.

Read the blog article
LynxCare at Frontiers Health 2024

From 17-18 October, we are attending Frontiers Health 2024 in Berlin, one of the most renowned events in digital health innovation. Jeanne Kehren (CEO) will be presenting LynxCare during the start-up and scale-up discovery session. 

Read the blog article
Driving Innovation in Mental Health

We successfully completed a pilot project in mental health in collaboration with Obasi, and supported by Johnson & Johnson.

Read the blog article
LynxCare recognized among the World's Best Digital Health Companies

We are proud to share that we have been recognized as one of the World's Best Digital Health Companies by Newsweek and Statista!

Read the blog article
LynxCare appoints Jeanne Kehren to new CEO

LynxCare appoints Jeanne Kehren as new Chief Executive Officer. She succeeds Georges De Feu, LynxCare’s visionary founder, who stepped aside from his position as CEO.

Read the blog article
Heart Failure Awareness Week

As Heart Failure Awareness Week comes to a close, we wanted to take a moment to reflect on the insights shared throughout the week. We've delved into various aspects of heart failure management, from the promise of AI-NLP technology to bridging the gaps in heart failure research.

Read the blog article
Former Chief Strategy Officer at Sanofi, Laurent van Lerberghe Joins LynxCare as Investor and Board Advisor

LynxCare is excited to announce the appointment of Laurent van Lerberghe, former Chief Strategy Officer at Sanofi, as Investor and Board Advisor. LynxCare is a scale-up company in Clinical Artificial Intelligence part of the CB Insights Global Digital Health 150, supported by renowned VC investors MTIP (CH), Elaia (FR), B2Ventures (CH-DE) and Heran partners (BE).

Read the blog article
Unlock Insights in Heart Failure

Through our comprehensive datasets, including an estimated 23.500 patients and 235 variables, you can gain further insights into the complexities of heart failure.

Read the blog article
Advancing Multiple Myeloma Research Through Unlocking Unstructured Hospital Data

Leveraging cutting-edge AI and disease-specific Clinical NLP, LynxCare unlocks the richness of hospital data (incl. narrative text in medical records - unstructured data), building harmonized databases. Hospitals and life sciences can in turn extract clinical insights from fresh Real-World Data for research and improving patient care.

Read the blog article

Find answers to complex clinical questions.

We have a team of MDs, data scientists and software engineers ready to let data drive your outcomes.